 SAN JOSE, Calif., May 03, 2022 GLOBE NEWSWIRE -- Rani Therapeutics Holdings, Inc. Rani Therapeutics or Rani Nasdaq: RANI, a clinical stage biotherapeutics company focused on the oral delivery of biologics, today announced that the companys Chief Executive Officer, Talat Imran, will present at two upcoming investor conferences in May: 